First Trimester Vitamin D, Vitamin D Binding Protein, and Subsequent Preeclampsia

Previous studies report an association between vitamin D deficiency and hypertension, including the pregnancy-specific disorder preeclampsia. Circulating vitamin D is almost entirely bound to vitamin D binding protein, which increases 2-fold during pregnancy and previous studies have not examined vitamin D binding protein or free vitamin D levels. We performed a nested case-control study within the Massachusetts General Hospital Obstetric Maternal Study, measuring first trimester total 25-hydroxyvitamin D (25[OH]D) and vitamin D binding protein and calculating free 25(OH)D levels. We compared these levels from pregnancies complicated by subsequent preeclampsia (cases, n=39) with those from normotensive pregnancies (controls, n=131). First trimester total 25(OH)D levels were similar in cases and controls (27.4±1.9 versus 28.8±0.80 ng/mL; P=0.435). Despite an association between higher first trimester blood pressures and subsequent preeclampsia, first trimester total 25(OH)D was not associated with first trimester systolic (r=0.11; P=0.16) or diastolic blood pressures (r=0.03; P=0.72). Although there was a trend toward increased risk of preeclampsia with 25(OH)D levels <15 ng/mL (odds ratio: 2.5 [95% CI: 0.89 to 6.90]), this was attenuated after adjustment for body mass index and other covariates (odds ratio: 1.35 [95% CI: 0.40 to 4.50]). First trimester vitamin D binding protein and free 25(OH)D levels were similar in cases and controls and were not associated with first trimester blood pressures. These data suggest that first trimester total and free 25(OH)D levels are not independently associated with first trimester blood pressure or subsequent preeclampsia.

[1]  M. Wolf,et al.  Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  A. Siega-Riz,et al.  The Impact of Exposure Misclassification on Associations Between Prepregnancy BMI and Adverse Pregnancy Outcomes , 2010, Obesity.

[3]  James J. Miller,et al.  Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. , 2009, Metabolism: clinical and experimental.

[4]  G. McCabe,et al.  Vitamin D status and calcium metabolism in adolescent black and white girls on a range of controlled calcium intakes. , 2008, The Journal of clinical endocrinology and metabolism.

[5]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[6]  T. Leet,et al.  Evaluation of Gestational Weight Gain Guidelines for Women With Normal Prepregnancy Body Mass Index , 2007, Obstetrics and gynecology.

[7]  M. Holick,et al.  Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  B. Dawson-Hughes,et al.  Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  I. Reid,et al.  Age‐, gender‐, and weight‐related effects on levels of 25‐hydroxyvitamin D are not mediated by vitamin D binding protein , 2007, Clinical endocrinology.

[10]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[11]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[12]  M. Visser,et al.  Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. , 2005, The Journal of clinical endocrinology and metabolism.

[13]  M. Holick,et al.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[14]  N. Stern,et al.  25-Hydroxyvitamin D3-1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds , 2005, Circulation.

[15]  A. Looker Body fat and vitamin D status in black versus white women. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  B. Raynor,et al.  Obstetric outcomes associated with increase in BMI category during pregnancy. , 2004, American journal of obstetrics and gynecology.

[17]  M. Wolf,et al.  Insulin Resistance But Not Inflammation Is Associated With Gestational Hypertension , 2002, Hypertension.

[18]  M. Wolf,et al.  First trimester insulin resistance and subsequent preeclampsia: a prospective study. , 2002, The Journal of clinical endocrinology and metabolism.

[19]  D. Wheeler,et al.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.

[20]  R. Thadhani,et al.  Obesity and Preeclampsia: The Potential Role of Inflammation , 2001, Obstetrics and gynecology.

[21]  R. Thadhani,et al.  Pulse Pressure and Risk of Preeclampsia: A Prospective Study , 2001, Obstetrics and gynecology.

[22]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[23]  F. Larrea,et al.  Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. , 2000, The Journal of clinical endocrinology and metabolism.

[24]  S. Liebhaber,et al.  Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. , 1999, The Journal of clinical investigation.

[25]  B. Metzger,et al.  Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. , 1998, Diabetes care.

[26]  A. Yergey,et al.  Pathophysiology of hypocalciuria in preeclampsia: Measurement of intestinal calcium absorption , 1994, Obstetrics and gynecology.

[27]  E. Brown,et al.  Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. , 1992, The Journal of clinical endocrinology and metabolism.

[28]  J. Laragh,et al.  Abnormal 1,25-dihydroxyvitamin D metabolism in preeclampsia. , 1992, American journal of obstetrics and gynecology.

[29]  M. Cullen,et al.  Urinary calcium as an early marker for preeclampsia , 1991, Obstetrics and gynecology.

[30]  R. Zimlichman,,et al.  Hypocalciuria of Preeclampsia Is Independent of Parathyroid Hormone Level , 1991, Obstetrics and gynecology.

[31]  S. Sandroni,et al.  Calcium Excretion in Preeclampsia , 1991, Obstetrics and gynecology.

[32]  C. Mendel The free hormone hypothesis: a physiologically based mathematical model. , 1989, Endocrine reviews.

[33]  M. Haussler,et al.  Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. , 1989, The Journal of clinical investigation.

[34]  J. Laragh,et al.  Hypocalciuria in preeclampsia. , 1987, The New England journal of medicine.

[35]  J. Haddad,et al.  Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. , 1986, The Journal of clinical endocrinology and metabolism.

[36]  P. Siiteri,et al.  Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. , 1985, The Journal of clinical endocrinology and metabolism.

[37]  J. Moutquin,et al.  A prospective study of blood pressure in pregnancy: prediction of preeclampsia. , 1985, American journal of obstetrics and gynecology.

[38]  J. Haddad,et al.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. , 1984, The Journal of clinical investigation.

[39]  P. D. de Moor,et al.  The measurement of the vitamin D-binding protein in human serum. , 1977, The Journal of clinical endocrinology and metabolism.

[40]  J. Haddad,et al.  Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. , 1976, The Journal of clinical investigation.

[41]  R. Lindsay,et al.  Biochemical Responses of Bone Metabolism to 1,25-Dihydroxyvitamin D Administration in Black and White Women , 2000, Osteoporosis International.